NCT07653984
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Autoimmune Encephalitis, +33 more
- Locations
-
- The Third Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
Clinical trial condition
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
Explore clinical trials studying Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD). Study availability and eligibility vary by location and protocol.
6 public trials
4 recruiting studies
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) trial results
NCT07202494
- Conditions
- Alzheimer Disease, Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), +50 more
- Locations
-
- Chu Timone Marseille, France
NCT05017142
- Conditions
- Acute Disseminated Encephalomyelitis, Anti-AMPAR-1/2 Associated Autoimmune Encephalitis, Anti-CASPR-2 Associated Autoimmune Encephalitis, +61 more
- Locations
-
- Kantonsspital Aarau Aarau, Canton of Aargau, Switzerland
- Children's Hospital of Eastern Switzerland Sankt Gallen, Canton of St. Gallen, Switzerland
- University Children's Hospital Lausanne (CHUV) Lausanne, Canton of Vaud, Switzerland
- Kantonsspital Winterthur Winterthur, Canton of Zurich, Switzerland
NCT04561557
- Conditions
- Abnormalities, Multiple, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +45 more
- Locations
-
- Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
Active, Not Recruiting
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOGAD)
NCT05063162
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +2 more
- Locations
-
- Mog001 50297 Scottsdale, Arizona, United States
- Mog001 50450 Palo Alto, California, United States
- Mog001 50101 Aurora, Colorado, United States
- Mog001 50553 Washington D.C., District of Columbia, United States
Active, Not Recruiting
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
NCT05271409
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +2 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California Irvine - Manchester Pavilion Irvine, California, United States
- University of Colorado - Anschutz Medical Campus (University of Colorado Health Sciences Center) Aurora, Colorado, United States
- Medstar Georgetown University Hospital Washington D.C., District of Columbia, United States